Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of translation at presynapse, modulating synaptic transmission

FMR1 FXR2 FXR1

2.17e-0731253GO:0099577
GeneOntologyBiologicalProcessregulation of translation at presynapse

FMR1 FXR2 FXR1

2.17e-0731253GO:0140244
GeneOntologyBiologicalProcessregulation of translation at synapse, modulating synaptic transmission

FMR1 FXR2 FXR1

1.78e-0591253GO:0099547
GeneOntologyBiologicalProcesscentral nervous system development

SOX6 KIF21B FMR1 INHBA FXR2 MINK1 SPTBN2 GART NFASC VIT DICER1 UFM1 HAPLN1 PTPN11 FXR1 ZNF76 RERE PLXNA1 AGTPBP1 CDON

3.37e-05119712520GO:0007417
GeneOntologyBiologicalProcesspositive regulation of long-term neuronal synaptic plasticity

FMR1 FXR2 FXR1

3.46e-05111253GO:0048170
GeneOntologyBiologicalProcessprotein localization to M-band

ANK2 OBSCN

3.64e-0521252GO:0036309
GeneOntologyBiologicalProcessorganelle assembly

RPL10L CFAP47 FLII FMR1 SPTBN2 TBC1D2B OBSCN OCRL EIF6 DICER1 CC2D2B FXR1 KIF15 RP1 CEP126 DHX29 ULK2 RPL10 KPNB1

5.48e-05113812519GO:0070925
GeneOntologyBiologicalProcessregulation of translation at synapse

FMR1 FXR2 FXR1

5.94e-05131253GO:0140243
GeneOntologyBiologicalProcessbrain development

SOX6 KIF21B INHBA FXR2 MINK1 SPTBN2 GART NFASC DICER1 UFM1 PTPN11 FXR1 RERE PLXNA1 AGTPBP1 CDON

6.35e-0585912516GO:0007420
GeneOntologyBiologicalProcessregulation of SA node cell action potential

ANK2 RYR2

1.09e-0431252GO:0098907
GeneOntologyBiologicalProcesshead development

SOX6 KIF21B INHBA FXR2 MINK1 SPTBN2 GART NFASC DICER1 UFM1 PTPN11 FXR1 RERE PLXNA1 AGTPBP1 CDON

1.39e-0491912516GO:0060322
GeneOntologyBiologicalProcessmembraneless organelle assembly

RPL10L FLII FMR1 OBSCN EIF6 DICER1 FXR1 KIF15 DHX29 RPL10 KPNB1

1.51e-0447512511GO:0140694
GeneOntologyBiologicalProcessregulation of atrial cardiac muscle cell action potential

ANK2 RYR2

2.17e-0441252GO:0098910
GeneOntologyBiologicalProcesseye morphogenesis

SP3 SAMD7 ZHX2 TENM3 RP1 AGTPBP1 CDON

2.49e-042041257GO:0048592
GeneOntologyCellularComponentparanodal junction

ANK2 SPTBN2 NFASC

3.57e-05111283GO:0033010
DomainAgenet

FMR1 FXR2 FXR1

2.93e-0731253PF05641
DomainAGENET_LIKE

FMR1 FXR2 FXR1

2.93e-0731253PS51641
DomainFXMRP1_C_core

FMR1 FXR2 FXR1

2.93e-0731253IPR022034
DomainAgenet-like_dom

FMR1 FXR2 FXR1

2.93e-0731253IPR008395
DomainFXMRP1_C_core

FMR1 FXR2 FXR1

2.93e-0731253PF12235
DomainSpy1

SPDYE2 SPDYE21 SPDYE2B SPDYE6

6.08e-07111254PF11357
DomainSpeedy

SPDYE2 SPDYE21 SPDYE2B SPDYE6

6.08e-07111254IPR020984
DomainFXR_C1

FXR2 FXR1

4.44e-0521252IPR032172
DomainRibosomal_L10e_CS

RPL10L RPL10

4.44e-0521252IPR018255
DomainFXR_C1

FXR2 FXR1

4.44e-0521252PF16096
DomainRibosomal_L10e

RPL10L RPL10

4.44e-0521252IPR001197
DomainRIBOSOMAL_L10E

RPL10L RPL10

4.44e-0521252PS01257
DomainRibosomal_L10e/L16

RPL10L RPL10

1.33e-0431252IPR016180
Domain-

RPL10L RPL10

1.33e-04312523.90.1170.10
DomainRibosomal_L16

RPL10L RPL10

1.33e-0431252PF00252
DomainGPR1/GPR3/GPR5

ADGRG5 ADGRG2

2.64e-0441252IPR003910
DomainDCX

DCDC2B RP1

6.55e-0461252SM00537
Domain-

DCDC2B RP1

9.13e-04712523.10.20.230
DomainDCX

DCDC2B RP1

9.13e-0471252PF03607
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

KIF21B FLII CTTNBP2 FMR1 ANK2 FXR2 MINK1 SPTBN2 MPDZ NFASC LUZP1 FXR1 KIF15 FAM120C ZNF516 DNM3 LRRC7 HERC2 RAB2A KPNB1

5.47e-109631302028671696
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

FLII FMR1 TCP1 FXR2 VPS13C NFASC LUZP1 HAPLN1 FXR1 MTHFD1 FAM120C LRRC7 HERC2

9.31e-094301301332581705
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

FLII CTTNBP2 FMR1 ANK2 TCP1 MINK1 SPTBN2 NFASC LUZP1 HAPLN1 CS FXR1 MTHFD1 FAM120C LRRC7 RAB2A PCDH1 DHX29 METAP2 RPL10 AGTPBP1 KPNB1

1.72e-0814311302237142655
Pubmed

ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.

FMR1 CENPB TCP1 FXR2 SSRP1 EIF6 FXR1 ZNF592 MTHFD1 DNM3 KPNB1

5.06e-083301301133301849
Pubmed

Spatial control of nucleoporin condensation by fragile X-related proteins.

FMR1 FXR2 FXR1

5.10e-083130332706158
Pubmed

The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.

FMR1 FXR2 FXR1

5.10e-08313037489725
Pubmed

Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.

FMR1 FXR2 FXR1

5.10e-08313038668200
Pubmed

Sub-synaptic, multiplexed analysis of proteins reveals Fragile X related protein 2 is mislocalized in Fmr1 KO synapses.

FMR1 FXR2 FXR1

5.10e-083130327770568
Pubmed

Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

FMR1 FXR2 FXR1

5.10e-083130319487368
Pubmed

Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

FMR1 FXR2 FXR1

5.10e-083130320442204
Pubmed

LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation.

FMR1 FXR2 FXR1

5.10e-083130338587486
Pubmed

Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.

FMR1 FXR2 FXR1

5.10e-08313039259278
Pubmed

Fragile X-related proteins regulate mammalian circadian behavioral rhythms.

FMR1 FXR2 FXR1

5.10e-083130318589395
Pubmed

Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression.

FMR1 FXR2 FXR1

5.10e-083130312417522
Pubmed

The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins.

FMR1 FXR2 FXR1

5.10e-083130310888599
Pubmed

Evidence that fragile X mental retardation protein is a negative regulator of translation.

FMR1 FXR2 FXR1

5.10e-083130311157796
Pubmed

Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

FMR1 FXR2 FXR1

5.10e-083130332878499
Pubmed

Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes.

FMR1 FXR2 FXR1

5.10e-083130326612855
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

FLII FOXK2 FMR1 ANK2 TCP1 FXR2 SPTBN2 LARP1B SSRP1 EIF6 DICER1 UFM1 LUZP1 FXR1 FAM120C HERC2 RAB2A METAP2 HCFC1 AGTPBP1

1.93e-0713711302036244648
Pubmed

A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein.

FMR1 FXR2 FXR1

2.04e-074130310556305
Pubmed

Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex.

FMR1 FXR2 FXR1

2.04e-074130310567518
Pubmed

The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons.

FMR1 FXR2 FXR1

2.04e-074130316571602
Pubmed

Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.

FMR1 FXR2 FXR1

2.04e-074130318664458
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 FLII FMR1 TCP1 VPS13C GART SSRP1 EIF6 DICER1 PTPN11 CS FXR1 MTHFD1 TOMM40 RAB2A DHX29 HCFC1 PLXNA1 RPL10 KPNB1

3.55e-0714251302030948266
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

RPL10L FMR1 TCP1 FXR2 LARP1B SSRP1 EIF6 CS FXR1 MTHFD1 FAM120C RAB2A RPL10 KPNB1

5.09e-077141301428302793
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FLII FMR1 FXR2 MINK1 OCRL LARP1B EIF6 DICER1 LUZP1 FXR1 FAM120C DHX29 METAP2 AGTPBP1

6.00e-077241301436232890
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CFAP47 UBQLNL TCP1 FXR2 VPS13C SPTBN2 OBSCN NFASC TBC1D4 ZNF592 MTHFD1 FAM120C LRRC7 RPL10

7.29e-077361301429676528
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

SP3 FOXK2 MINK1 MPDZ ZNF217 SSRP1 POLR1G ZHX2 EIF6 DICER1 LUZP1 ZNF592 MTHFD1 FAM120C MED25 TOMM40 HERC2 DHX29 ZHX1 RPL10

7.66e-0714971302031527615
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

FLII FOXK2 FMR1 TCP1 FXR2 GART SSRP1 FXR1 ZNF592 MTHFD1 KPNB1

9.05e-074411301131239290
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RPL10L FLII FMR1 TCP1 FXR2 GART ZNF217 SSRP1 EIF6 WTAP LUZP1 FXR1 TBC1D4 MTHFD1 RAB2A HCFC1 RPL10 KPNB1

9.77e-0712471301827684187
Pubmed

A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.

FMR1 FXR2 FXR1

1.01e-066130311438699
Pubmed

In vivo assembly of the axon initial segment in motor neurons.

ANK2 SPTBN2 NFASC

1.01e-066130323728480
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SOX6 NRBP1 USP34 FLII ANK2 GNPTAB SPTBN2 ADAMTS8 ITGB8 ZNF181 CS ZNF592 DNM3 ZNF76 HERC2 METAP2 AGTPBP1 KPNB1

1.49e-0612851301835914814
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

CTTNBP2 FMR1 ANK2 OBSCN ZNF181 PTPN11 TBC1D4 ZNF592 MED12L AGTPBP1 KPNB1

2.87e-064971301123414517
Pubmed

C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions.

FMR1 FXR2 FXR1 RPL10

3.06e-0627130429420262
Pubmed

LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.

FLII TCP1 FXR2 SSRP1 EIF6 CS FXR1 MTHFD1 KPNB1

4.18e-06327130931409639
Pubmed

Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene.

SPDYE2 SPDYE2B SPDYE6

4.22e-069130336272447
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

USP34 FMR1 CENPB FXR2 SSRP1 POLR1G DICER1 LUZP1 FXR1 TIMM21 ZNF592 FAM120C FOXL2NB BICRAL RERE AGTPBP1

4.49e-0611161301631753913
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

FLII FMR1 CENPB FXR2 SSRP1 EIF6 WTAP FXR1 DHX29

4.73e-06332130925693804
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

FLII FMR1 TCP1 FXR2 SPTBN2 GART SSRP1 EIF6 WTAP LUZP1 PLEK2 FXR1 MTHFD1 TOMM40 METAP2 RPL10 KPNB1

4.78e-0612571301736526897
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

CTTNBP2 ANK2 MINK1 SPTBN2 MPDZ NFASC LRRC7 RAB2A

5.01e-06251130827507650
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

FLII FMR1 CENPB FXR2 SSRP1 POLR1G EIF6 WTAP FXR1 HERC2 DHX29 RPL10 AGTPBP1

5.79e-067591301335915203
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

FLII FOXK2 TCP1 FXR2 SPTBN2 GART MPDZ SSRP1 EIF6 LUZP1 FXR1 TBC1D4 MTHFD1 HCFC1 RPL10 KPNB1

6.47e-0611491301635446349
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

USP34 FMR1 FXR2 SPTBN2 GART EIF6 DICER1 FXR1 HERC2 HCFC1 RPL10 KPNB1

6.67e-066531301222586326
Pubmed

VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma.

FMR1 TCP1 FXR1 MTHFD1 RPL10 KPNB1

6.88e-06122130636929488
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FLII MINK1 ZNF217 SSRP1 POLR1G WTAP TBC1D4 ZNF592 ZNF516 RERE DHX29 ZHX1 AGTPBP1

7.13e-067741301315302935
Pubmed

FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124.

FMR1 FXR2 FXR1

8.24e-0611130321957233
Pubmed

Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus.

FMR1 FXR2 FXR1

8.24e-0611130322022532
Pubmed

Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma.

FMR1 FXR2 FXR1

8.24e-0611130329142209
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

FLII FMR1 SPTBN2 MPDZ LARP1B LUZP1 FXR1 KPNB1

9.50e-06274130834244482
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

FLII FMR1 FXR2 GART CS FXR1 MTHFD1 ELL RPL10 KPNB1

1.02e-054631301034901782
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

RPL10L USP34 FLII TCP1 GART MPDZ SSRP1 EIF6 DICER1 WTAP CS FXR1 TBC1D4 MTHFD1 HCFC1 RPL10 KPNB1

1.05e-0513351301729229926
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

FMR1 ANK2 MINK1 SPTBN2 LUZP1 LRRC7 RAB2A PCDH1

1.14e-05281130828706196
Pubmed

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.

FOXK2 FMR1 FXR2 EIF6 DICER1 IRF9 ZNF516 HCFC1

1.20e-05283130821903422
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

FLII TCP1 GART OCRL SSRP1 POLR1G EIF6 LUZP1 PLEK2 CS FXR1 TBC1D4 MTHFD1 HERC2 DHX29 METAP2 KPNB1

1.25e-0513531301729467282
Pubmed

The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses.

FMR1 FXR1

1.39e-052130212581522
Pubmed

Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

ANK2 FXR1

1.39e-052130218790697
Pubmed

Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1.

FMR1 FXR1

1.39e-05213028634689
Pubmed

On the aggregation properties of FMRP--a link with the FXTAS syndrome?

FMR1 FXR2

1.39e-052130221446998
Pubmed

Zinc finger proteins orchestrate active gene silencing during embryonic stem cell differentiation.

ZNF217 ZNF516

1.39e-052130229846698
Pubmed

Phosphorylation of FMRP inhibits association with Dicer.

FMR1 DICER1

1.39e-052130219155329
Pubmed

Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs.

FMR1 FXR1

1.39e-052130217057366
Pubmed

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits.

FMR1 FXR2

1.39e-052130219193898
Pubmed

Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.

FXR2 FXR1

1.39e-052130221072162
Pubmed

Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

FXR2 FXR1

1.39e-052130210196376
Pubmed

Exome sequencing in patients with microphthalmia, anophthalmia, and coloboma (MAC) from a consanguineous population.

TENM3 CDON

1.39e-052130232799327
Pubmed

The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis.

FMR1 FXR1

1.39e-052130216000371
Pubmed

Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2.

FXR2 FXR1

1.39e-052130211735223
Pubmed

PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1.

PCDH1 KPNB1

1.39e-052130235864095
Pubmed

Deficient Sleep in Mouse Models of Fragile X Syndrome.

FMR1 FXR2

1.39e-052130228919851
Pubmed

Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

FMR1 FXR2

1.39e-052130219244359
Pubmed

FXR1, an autosomal homolog of the fragile X mental retardation gene.

FMR1 FXR1

1.39e-05213027781595
Pubmed

Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.

FMR1 FXR1

1.39e-052130210527928
Pubmed

Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.

FMR1 FXR2

1.39e-052130216675531
Pubmed

The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.

FMR1 FXR2

1.39e-052130225552647
Pubmed

Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.

SPDYE2 SPDYE2B SPDYE6

1.42e-0513130315611625
Pubmed

Functional proteomics mapping of a human signaling pathway.

PSG9 RYR2 ZFYVE9 TENM3 ZNF592 TRIM62 CSPG4 ZNF76 HERC2 PCDH1 KPNB1

1.46e-055911301115231748
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ANK2 TCP1 MINK1 GART MPDZ OCRL PTPN11 MTHFD1 LRRC7 DHX29 HCFC1 KPNB1

1.49e-057081301239231216
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

KIF21B FLII SPTBN2 TBC1D2B OBSCN KIF15 ZNF592 MTHFD1 RP1 HCFC1

1.87e-054971301036774506
Pubmed

ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.

FMR1 CENPB TCP1 FXR2 LUZP1 FXR1 MTHFD1 KPNB1

2.59e-05315130826777405
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

USP34 POLH ZNF217 LUZP1 TBC1D4 KIF15 ZNF592 ZNF516 RERE

2.94e-05418130934709266
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

NRBP1 USP34 FLII TCP1 GART SSRP1 EIF6 UFM1 PTPN11 CS TBC1D4 KIF15 MTHFD1 METAP2 HCFC1 RPL10 KPNB1

3.13e-0514551301722863883
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KIF21B USP34 VPS13C TBC1D2B NFASC DICER1 ZNF592 ZNF516 MED12L CEP126

3.18e-055291301014621295
Pubmed

Characterization of a new family of cyclin-dependent kinase activators.

SPDYE2 SPDYE2B SPDYE6

3.34e-0517130315574121
Pubmed

Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation.

KIF21B TCP1 PSG9 CS MTHFD1 TOMM40 RPL10 KPNB1

3.37e-05327130834428256
Pubmed

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

FXR2 GART SSRP1 EIF6 DICER1 PTPN11 FXR1 PCDH1

3.37e-05327130815592455
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

TCP1 FXR2 GART SSRP1 POLR1G EIF6 PLEK2 CS FXR1 MTHFD1 TOMM40 RAB2A METAP2 HCFC1 RPL10 KPNB1

3.46e-0513181301630463901
Pubmed

Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.

FMR1 ANK2 FXR2 WTAP FXR1

4.01e-05101130526949739
Pubmed

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

PAPLN HAPLN1 TGFBI CSPG4 LTBP1 HCFC1

4.09e-05167130622159717
Pubmed

Evolution of the Cdk-activator Speedy/RINGO in vertebrates.

SPDYE2 SPDYE6

4.15e-053130222763696
Pubmed

Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms.

FMR1 FXR2

4.15e-053130226051932
Pubmed

Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations.

GART MTHFD1

4.15e-05313022183217
Pubmed

Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma.

ZHX2 ZHX1

4.15e-053130228152006
Pubmed

Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression.

SP3 TGFBI

4.15e-053130221554857
Pubmed

Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor.

ZHX2 ZHX1

4.15e-053130212741956
Pubmed

Growth differentiation factor 9 reverses activin A suppression of steroidogenic acute regulatory protein expression and progesterone production in human granulosa-lutein cells.

INHBA GDF9

4.15e-053130220660033
Pubmed

Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.

ANK2 RYR2

4.15e-053130227005929
Pubmed

The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

MPDZ CSPG4

4.15e-053130210967549
Pubmed

Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.

ANK2 OBSCN

4.15e-053130218782775
Pubmed

FXR2P Exerts a Positive Translational Control and Is Required for the Activity-Dependent Increase of PSD95 Expression.

FMR1 FXR2

4.15e-053130226109663
InteractionHDAC2 interactions

SOX6 FLII SP3 FOXK2 FMR1 TCP1 FXR2 PLEKHA4 ZNF217 ZHX2 FXR1 ZNF516 LTBP1 RERE HERC2 ZHX1 HCFC1 RPL10 KPNB1

1.79e-0686512619int:HDAC2
InteractionGSK3B interactions

NRBP1 FMR1 CENPB TCP1 GART PLEKHA4 MPDZ LARP1B SSRP1 DICER1 UFM1 LUZP1 PTPN11 FXR1 TBC1D4 MTHFD1 HERC2 ZHX1 KPNB1

1.89e-0686812619int:GSK3B
InteractionSLC6A4 interactions

FLII FMR1 TCP1 FXR2 VPS13C NFASC LUZP1 HAPLN1 FXR1 MTHFD1 FAM120C LRRC7 HERC2

3.63e-0643712613int:SLC6A4
InteractionTNIK interactions

CTTNBP2 FMR1 ANK2 FXR2 MINK1 SPTBN2 PLEKHA4 FXR1 LRRC7 HERC2 C11orf52 AGTPBP1

4.93e-0638112612int:TNIK
InteractionHDAC1 interactions

SOX6 FLII SP3 FOXK2 TCP1 POLH PLEKHA4 ZNF217 POLR1G ZHX2 LUZP1 TBC1D4 KIF15 ZNF592 ZNF516 ZNF76 RERE ZHX1 HCFC1 ELL KPNB1

4.98e-06110812621int:HDAC1
InteractionTRIM3 interactions

KIF21B FMR1 FXR2 PLEKHA4 FXR1 KPNB1

1.09e-05801266int:TRIM3
InteractionPRRC2C interactions

SOX6 FOXK2 FMR1 TCP1 FXR2 PLEKHA4 FXR1 FAM120C HCFC1 RPL10

1.45e-0529012610int:PRRC2C
InteractionSYNGAP1 interactions

FMR1 ANK2 MINK1 SPTBN2 MPDZ CS LRRC7 RAB2A DHX29 ULK2

2.36e-0530712610int:SYNGAP1
InteractionZMYND8 interactions

FMR1 FXR2 SSRP1 POLR1G LUZP1 ZFYVE9 ZNF592 RERE

2.72e-051911268int:ZMYND8
InteractionKIF20A interactions

RPL10L FLII FMR1 ANK2 CENPB FXR2 POLH MINK1 SPTBN2 PLEKHA4 SSRP1 POLR1G LUZP1 CS FXR1 TOMM40 HERC2 RPL10 KPNB1

2.89e-05105212619int:KIF20A
InteractionGLDC interactions

FLII FMR1 SPTBN2 PLEKHA4 MPDZ LARP1B LUZP1 FXR1 NUDT6 KPNB1

3.45e-0532112610int:GLDC
InteractionTRIP4 interactions

RPL10L FMR1 TCP1 PLEKHA4 LUZP1 FXR1 MED25 RAB2A

4.66e-052061268int:TRIP4
InteractionKCTD13 interactions

FLII CTTNBP2 FMR1 ANK2 TCP1 MINK1 SPTBN2 NFASC LUZP1 HAPLN1 CS FXR1 MTHFD1 FAM120C LRRC7 RAB2A PCDH1 DHX29 METAP2 RPL10 AGTPBP1 KPNB1

4.97e-05139412622int:KCTD13
InteractionCD6 interactions

FOXK2 FMR1 FXR2 OCRL POLR1G FXR1 ZNF592

5.24e-051541267int:CD6
InteractionCTNNB1 interactions

SOX6 FLII FMR1 ANK2 TCP1 PLEKHA4 MPDZ SSRP1 EIF6 PTPN11 FXR1 ZFYVE9 MTHFD1 HERC2 RPL10 C11orf52 CDON KPNB1

5.63e-05100912618int:CTNNB1
InteractionEFL1 interactions

SP3 TCP1 PLEKHA4 EIF6 UFM1

7.20e-05691265int:EFL1
InteractionHNRNPU interactions

RPL10L FLII FMR1 GNPTAB GART PLEKHA4 LARP1B SSRP1 EIF6 WTAP PTPN11 FXR1 FAM120C RAB2A DHX29 ELL RPL10 KPNB1

7.79e-05103512618int:HNRNPU
InteractionGRIP2 interactions

FMR1 FXR1 CSPG4

8.26e-05141263int:GRIP2
InteractionZNRD2 interactions

USP34 CABLES2 FLII FMR1 FXR2 MINK1 PLEK2 LRRC7 HERC2

8.40e-052881269int:ZNRD2
InteractionDYNLL1 interactions

CTTNBP2 FMR1 POLH MINK1 PLEKHA4 WTAP CS FXR1 DNM3 RERE ZHX1 ELL

8.65e-0551012612int:DYNLL1
InteractionAAMP interactions

FXR2 PLEKHA4 SSRP1 DICER1 RPL10

1.07e-04751265int:AAMP
InteractionTOP3B interactions

USP34 FLII FOXK2 FMR1 FXR2 SPTBN2 OBSCN PLEKHA4 PAPLN SSRP1 EIF6 FXR1 ZNF592 FAM120C CSPG4 ZNF516 HERC2 ULK2 HCFC1 PLXNA1 ELL RPL10

1.09e-04147012622int:TOP3B
InteractionCYFIP1 interactions

FMR1 ANK2 FXR2 SPTBN2 PLEKHA4 FXR1 CSNK1G3 DNM3 C11orf52

1.23e-043031269int:CYFIP1
InteractionZBTB2 interactions

FMR1 CENPB TCP1 FXR2 SSRP1 EIF6 FXR1 ZNF592 MTHFD1 DNM3 KPNB1

1.24e-0445012611int:ZBTB2
InteractionKIF2A interactions

NRBP1 FMR1 CEBPG FXR2 PLEKHA4 LARP1B LUZP1 FXR1

1.43e-042421268int:KIF2A
InteractionILF3 interactions

FMR1 FXR2 GART PLEKHA4 LARP1B SSRP1 GDF9 DICER1 IRF9 PTPN11 FXR1 MTHFD1 RAB2A METAP2 RPL10 KPNB1

1.49e-0489612616int:ILF3
InteractionCSNK2B interactions

NRBP1 CENPB FXR2 MINK1 PLEKHA4 SSRP1 ZHX2 EIF6 FXR1 ZNF592 ZNF516 ZHX1 HCFC1

1.50e-0462512613int:CSNK2B
InteractionGSK3A interactions

FMR1 FXR2 TTC16 PLEKHA4 MPDZ LARP1B DICER1 LUZP1 FXR1 TBC1D4 RPL10

1.61e-0446412611int:GSK3A
InteractionASF1A interactions

SOX6 FOXK2 CENPB SPTBN2 ZNF592 ZNF516 HCFC1 ELL

1.74e-042491268int:ASF1A
InteractionPPP1CB interactions

NRBP1 FLII SPTBN2 GART PLEKHA4 SSRP1 RYR2 LUZP1 ZFYVE9 HCFC1 KPNB1

1.77e-0446912611int:PPP1CB
GeneFamilySpeedy/RINGO cell cycle regulator family

SPDYE2 SPDYE2B SPDYE6

2.54e-0512903756
GeneFamilyAdhesion G protein-coupled receptors, subfamily G

ADGRG5 ADGRG2

5.06e-047902917
GeneFamilyDoublecortin superfamily

DCDC2B RP1

1.07e-03109021369
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

OBSCN NFASC PAPLN IGSF11 CDON

1.26e-03161905593
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZHX2 ZHX1

2.47e-0315902529
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBML5

KIF21B ANK2 GNPTAB ZNF195 NFASC LARP1B DICER1 RYR2 MED12L DNM3 CEP126 ZHX1

3.39e-0646512912M39066
CoexpressionZHONG_PFC_C3_MICROGLIA

KIF21B ANK2 TCP1 FXR2 NFASC KIAA1549L DNM3 LRRC7 CEP126 PLXNA1 AGTPBP1 KPNB1

5.54e-0648812912M39104
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

SOX6 SP3 CEBPG ANK2 GART TBC1D2B ZNF217 LARP1B DICER1 ITGB8 TENM3 DNM3 RERE HERC2 MAP2K5 PLXNA1 CDON

9.63e-06100912917M157
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HRGL1

SOX6 VIT ITGB8 KIAA1549L TENM3 MED12L LTBP1 CEP126 RAB2A CDON

1.34e-0536412910M39057
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

KIF21B ANK2 GNPTAB TBC1D2B NFASC OCRL LARP1B DICER1 RYR2 KIAA1549L DNM3 LRRC7 CEP126 PCDH1 PLXNA1 AGTPBP1 CDON

3.11e-05110612917M39071
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HDA2

SOX6 KIF21B GNPTAB NFASC DNM3 LRRC7 BICRAL CEP126 PCDH1 ULK2 CDON

4.83e-0551312911M39069
CoexpressionGSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN

KIF21B SP3 ZHX2 ITGB8 NUDT6 ZNF592 HERC2

6.18e-052001297M9765
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN

CEBPG ANK2 GART TBC1D2B ZNF217 DICER1 ITGB8 TENM3 DNM3 CDON

6.43e-0543812910M227
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 NFASC PAPLN VIT ADGRG2 LTBP1 CDON

1.59e-061941297f9fbb043411546d8c9e0321a64165d411f44aeb7
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ANK2 ADAMTS8 ITGB8 WTAP RYR2 TENM3 LTBP1

1.89e-0619912978b86c69aaf60feff53aa782559cfece7342a23de
ToppCellControl-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations)

ANK2 NFASC PAPLN TENM3 ADGRG2 LTBP1

3.25e-061391296e769beb031b262dd92c9605b07dbf3c29fb82520
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

OCRL CC2D2B PLEK2 TGFBI ZNF516 RPL10

1.10e-051721296ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

OCRL CC2D2B PLEK2 TGFBI ZNF516 RPL10

1.10e-0517212963fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556
ToppCellPND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass

ANK2 TGFBI NUDT6 TENM3 ADGRG2 LTBP1

1.52e-051821296812dac35b9aa05be48258082e007f6c00e7b4dd8
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ANK2 HAPLN1 TENM3 LRRC7 LTBP1 CDON

1.72e-0518612964d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBC1D2B PAPLN ADAMTS8 RYR2 TENM3 ELL

2.00e-05191129608720998aa55131d7377c4c67c4c935865bd7d79
ToppCellASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

ANK2 NFASC ADAMTS8 RYR2 CSPG4 VEGFD

2.00e-051911296e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCellASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

ANK2 NFASC ADAMTS8 RYR2 CSPG4 VEGFD

2.00e-0519112961726add3f392a061536b7aff72ba84303f4a0b1f
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SOX6 INHBA HAPLN1 TENM3 CSPG4 CDON

2.00e-051911296f9a46956778a8773d6656340ecf5d218376d79c2
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ANK2 NFASC ADAMTS8 RYR2 TENM3 LTBP1

2.06e-05192129699ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellFibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CTTNBP2 PAPLN ITGB8 ADGRG2 CSPG4 CDON

2.12e-0519312968f4bf9a2fbedae35432dad96730b00c70185874c
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster

CTTNBP2 ANK2 INHBA ADGRG2 LRRC7 RPL10

2.12e-0519312963b927d4b8ecb21a408424ef91a23746c21741f49
ToppCellMild_COVID-19|World / Disease group,lineage and cell class （2021.01.30）

MINK1 PLEKHA4 PTCHD4 IRF9 TBC1D4 SLC47A1

2.12e-051931296325b0768827bf8701bfb7f686bb11fd8b1a41a5c
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 NFASC PAPLN VIT ADGRG2 LTBP1

2.24e-0519512961be9502577267ca2a04656a99d57e3e2f124d92e
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK2 ADAMTS8 RYR2 TENM3 LRRC7 LTBP1

2.38e-051971296fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster

SOX6 ITGB8 KIF15 NFATC4 LTBP1 CDON

2.38e-05197129661749ccafeb938c310cff1de5ff924a1c794325a
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster

SOX6 ITGB8 KIF15 NFATC4 LTBP1 CDON

2.38e-0519712969d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCellTracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

INHBA PLEKHA4 PAPLN VIT DNM3 LTBP1

2.51e-051991296fbec5c034576cb1adaf05f6f97cc5525d19e0c1b
ToppCellFibroblasts|World / lung cells shred on cell class, cell subclass, sample id

NFASC ADAMTS8 RYR2 TENM3 LTBP1 VEGFD

2.51e-051991296e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

ANK2 PLEKHA4 ADAMTS8 WTAP TENM3 LTBP1

2.51e-051991296fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ANK2 ADAMTS8 RYR2 TENM3 LTBP1 VEGFD

2.51e-051991296a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 INHBA PLEKHA4 PAPLN VIT LRRC7

2.51e-0519912963835452e4848d7f7dd8651c17b746b271ef39688
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

ANK2 ADAMTS8 WTAP TENM3 LTBP1 VEGFD

2.51e-051991296211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANKRD31 TTC16 DCDC2B RP1 CEP126 KIAA2012

2.51e-05199129615f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NFASC ADAMTS8 RYR2 CSPG4 LTBP1 RPL10

2.51e-051991296b768496381362f9a2706e0892b5a7a0db82e09ce
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 INHBA PLEKHA4 PAPLN VIT LRRC7

2.51e-0519912969c2db0bb94cba71a3cc1827844da090e213e0258
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

ANK2 ADAMTS8 WTAP TENM3 LTBP1 VEGFD

2.51e-0519912961a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellCOVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type

INHBA NFASC TGFBI TENM3 NFATC4 LTBP1

2.51e-0519912969503646ff1ad248181146ce767e9d12e882ec3bd
ToppCellParenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

OBSCN RYR2 HAPLN1 NFATC4 CSPG4 PCDH1

2.59e-0520012960c648941447c738caf62f2d71e296d6cca492c8b
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

OBSCN RYR2 HAPLN1 NFATC4 CSPG4 PCDH1

2.59e-052001296522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 NFASC ADAMTS8 RYR2 TENM3 LTBP1

2.59e-052001296cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

OBSCN RYR2 HAPLN1 NFATC4 CSPG4 PCDH1

2.59e-05200129694f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 NFASC ADAMTS8 RYR2 TENM3 LTBP1

2.59e-052001296311fab076f2ceb258e3970eb21e39344b894042a
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

CFAP47 ADAMTS8 VIT ANKDD1B

8.20e-05791294cc17a013a4a57a99c404b10449ef61ce559631d1
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(Neuron.Gad1Gad2.Pvalb-Unc5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

CFAP47 ADAMTS8 VIT ANKDD1B

8.20e-0579129419fb2bc964589ea40e7b9f0809c641331c93dacd
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

INHBA ITGB8 SLC47A1 KIAA2012 ULK2

8.61e-0515412956c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCellPND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

TMEM221 NFASC PTCHD4 RYR2 CDON

9.15e-051561295574f761962a7dd3308bd41fc529dd3ea1b8625f8
ToppCellPND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass

TMEM221 NFASC PTCHD4 RYR2 CDON

9.15e-051561295605d95a900e1443d3f6aae163ef2e893d3293203
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TBC1D2B MPDZ IGSF11 HAPLN1 TRIM62

1.00e-0415912950dccc4275b9b4f8554dd556da7218e130bff8fd1
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFASC IGSF11 RYR2 KIAA1549L POLN

1.03e-041601295f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41
ToppCellControl-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations)

ANKRD31 NRBP1 CTTNBP2 IGSF11 SPDYE21

1.06e-0416112955807ee48f871a3eb24ebf78fd107cf5f2a4ec846
ToppCellBronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 NFASC OCRL ITGB8 KIAA1549L

1.09e-041621295afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCelllung-Ciliated_Epithelia|lung / shred on tissue and cell subclass

TTC16 DCDC2B RP1 CEP126 KIAA2012

1.26e-04167129526cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTBN2 FXR1 ZNF516 DNM3 PCDH1

1.26e-041671295528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTBN2 FXR1 ZNF516 DNM3 PCDH1

1.26e-041671295a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCellCOVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type

SOX6 ANK2 IGSF11 ITGB8 TENM3

1.30e-04168129588c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCellCOVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type

SOX6 CTTNBP2 PAPLN ITGB8 TENM3

1.30e-041681295a086c306be430adf0632ba53e98cd8014d2de330
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

OCRL CC2D2B PLEK2 ZNF516 RPL10

1.33e-041691295a0681317867e31319210a23e56660a53f4529efe
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TTC16 DCDC2B RP1 CEP126 POLN

1.33e-0416912958bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NFASC PAPLN VIT ADGRG2 LTBP1

1.33e-04169129549a54fb2ea9db5c45e107f304838c536908308bb
ToppCellCOVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type

ANK2 IGSF11 ADAMTS8 ITGB8 TENM3

1.49e-0417312956fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCellwk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SOX6 INHBA HAPLN1 TENM3 LTBP1

1.61e-0417612951af28b701c4598ce761f85adbd5d79e4918d265a
ToppCell5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 OBSCN NFASC VEGFD CDON

1.65e-041771295bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCDC2B POLR1G ZFYVE9 TIMM21 PLXNA1

1.65e-041771295e1e45956887371b1c18f1eb479dd930031497520
ToppCellwk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SOX6 HAPLN1 CC2D2B TENM3 CSPG4

1.65e-041771295b01d7a6a78169962123ddfb0bb588f51d138ad02
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

SOX6 CTTNBP2 PAPLN ITGB8 TENM3

1.70e-041781295544379f5a6145429762258d426b876bb36c112f5
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM6 ADAMTS8 ITGB8 ADGRG2 CSPG4

1.74e-041791295e880c507f11ce75d104593a4ca29f0295f8125e8
ToppCell5'-Adult-SmallIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 IGSF11 ADAMTS8 ITGB8 TENM3

1.79e-0418012955e6e38ee0758ef2342a6a821c78ed24b57bb7b11
ToppCell390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells)

ADAMTS8 PTCHD4 TENM3 ADGRG2 VEGFD

1.79e-041801295137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue

TRPM6 SPTBN2 ITGB8 MED12L LTBP1

1.79e-041801295b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCell5'-Adult-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 IGSF11 ADAMTS8 ITGB8 TENM3

1.79e-041801295b88cd7ae922782176c057342d1b9eb9b8e5e7204
ToppCell5'-Adult-SmallIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANK2 IGSF11 ADAMTS8 ITGB8 TENM3

1.79e-041801295ebd6e719a03f25155fa8181be19469d04d6d10a6
ToppCell390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells)

ADAMTS8 PTCHD4 TENM3 ADGRG2 VEGFD

1.79e-041801295cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CTTNBP2 ANK2 PTCHD4 ITGB8 DNM3

1.83e-0418112959d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCellwk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SOX6 HAPLN1 TENM3 CSPG4 C11orf52

1.83e-0418112958950844b3e65c7028d80da5787ae2ce509c3d52d
ToppCellPericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

CTTNBP2 NFASC ADAMTS8 CSPG4 LTBP1

1.83e-041811295ff445a8e56522e57e27405184d123cf905caf8cc
ToppCellAdult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor

CFAP47 TTC16 DCDC2B RP1 KIAA2012

1.88e-0418212957ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CTTNBP2 ANK2 PTCHD4 ITGB8 DNM3

1.88e-041821295eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCellwk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SOX6 INHBA HAPLN1 TENM3 CSPG4

1.88e-04182129500a148b1e499bf16325491536d187d4dd6b70c06
ToppCellNS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CTTNBP2 ANK2 TBC1D4 TENM3 ADGRG2

1.93e-041831295ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCellLPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CEBPG LARP1B WTAP LUZP1 PTPN11

1.98e-041841295c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

ANK2 OBSCN RYR2 TBC1D4 LTBP1

1.98e-041841295ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ANK2 INHBA RYR2 TENM3 LRRC7

2.03e-0418512957dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANK2 PAPLN ADAMTS8 RYR2 VEGFD

2.08e-0418612955473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBC1D2B OBSCN RYR2 NFATC4 CSPG4

2.08e-041861295888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

USP34 SP3 GNPTAB LUZP1 DCAF17

2.08e-04186129503db813598b67b1e08f759758a1c2023396921fa
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ANK2 TENM3 DNM3 LRRC7 LTBP1

2.13e-0418712955258674d0346e5c51a4b965efcdc1790c970845d
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEK2 MED12L DNM3 ANKDD1B LTBP1

2.13e-04187129546e15419e80bd7180f3171a99d845b01bb635e53
ToppCellmetastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass

ANK2 MPDZ PAPLN ADGRG2 LTBP1

2.13e-041871295e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEK2 MED12L DNM3 ANKDD1B LTBP1

2.13e-0418712950d17b07770e4c881a7ca53a5bd42471457d198fb
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEK2 MED12L DNM3 ANKDD1B LTBP1

2.13e-04187129569068480f6819a6c8560ecbb05deb156b4055e12
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRG5 ANK2 PAPLN ITGB8 SLC47A1

2.13e-0418712959d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PLEK2 MED12L DNM3 ANKDD1B LTBP1

2.13e-0418712959c8b932a15b8b50982cba4cf8db750e257eb9503
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CTTNBP2 ANK2 ITGB8 DNM3 RP1

2.13e-041871295c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

ANK2 OBSCN RYR2 LRRC7 LTBP1

2.19e-0418812956d249fe92d51a19da19ec14bb2262d394255d577
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SOX6 IGSF11 HAPLN1 ADGRG2 C11orf52

2.19e-041881295340f0e3e65c7a00d82d26621ff37107458bebc41
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TCP1 RYR2 LUZP1 ZFYVE9 LTBP1

2.19e-0418812956468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TCP1 RYR2 LUZP1 ZFYVE9 LTBP1

2.19e-0418812957a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCelldroplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX6 INHBA RYR2 CSPG4 RPL10

2.19e-04188129561f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

OVCH2 PAPLN ADAMTS8 LRRC7 LTBP1

2.19e-04188129574f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TCP1 RYR2 LUZP1 ZFYVE9 LTBP1

2.19e-0418812959cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCelldroplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX6 INHBA RYR2 CSPG4 RPL10

2.19e-0418812957553ef7de3575af4cf34704b405b551c1af8eb83
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SOX6 IGSF11 HAPLN1 ADGRG2 C11orf52

2.19e-0418812959d384c0934f1461bc37b1f83e0877d7bee2116ee
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

INHBA ADAMTS8 PTCHD4 LRRC7 LTBP1

2.19e-041881295f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SOX6 CTTNBP2 OBSCN PAPLN TGFBI

2.19e-041881295997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SOX6 PTCHD4 HAPLN1 TENM3 SLC47A1

2.19e-0418812958de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

INHBA HAPLN1 ADGRG2 VEGFD CDON

2.19e-0418812950e2d1b21f0a7ee306e7dae16fc8c19d16a467883
ToppCell3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

INHBA NFASC RYR2 CSPG4 LTBP1

2.24e-041891295d69b7a01dd4d6ad043bb6210e9ab34b49578389c
DrugIsocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A

KIF21B MINK1 GART DICER1 RYR2 LUZP1 ZNF592 NFATC4 FAM120C MED25 RPL10

1.39e-08198126113424_UP
DrugButirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A

GNPTAB MINK1 LUZP1 ZFYVE9 RAB2A MAP2K5 PCDH1 ULK2 PLXNA1

1.63e-0619812696080_DN
DrugZoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A

FXR2 TBC1D2B ITGB8 LUZP1 ZFYVE9 RERE MAP2K5 ELL RPL10

1.69e-0619912692625_UP
DrugMetoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A

MINK1 TBC1D2B ZHX2 HAPLN1 ZFYVE9 ZNF76 BICRAL MAP2K5

1.23e-0519312684285_DN
Drug(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A

GART ZHX2 ADGRG2 MED25 RERE RAB2A ULK2 HCFC1

1.54e-0519912684543_DN
Drugpotassium hydride

SP3 FMR1 FXR2 PTPN11 CS FXR1

7.97e-051281266CID000082127
DrugAcetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A

MINK1 MPDZ IRF9 ZFYVE9 ADGRG2 PCDH1 ULK2

9.85e-0519212671829_UP
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

INHBA POLH MINK1 RYR2 MAP2K5 ELL RPL10

1.02e-0419312671652_UP
DrugTridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A

FXR2 TBC1D2B ITGB8 FAM120C MAP2K5 HCFC1 CDON

1.05e-0419412673526_UP
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A

RYR2 HAPLN1 MED25 DNM3 BICRAL RERE HCFC1

1.05e-0419412674559_DN
DrugF de

MINK1 ELL RPL10

1.06e-04171263CID009547898
Drugwortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A

GNPTAB ITGB8 ZNF516 MED25 SLC47A1 RERE CDON

1.09e-0419512674467_UP
DrugAzapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A

INHBA GART OCRL ZFYVE9 ADGRG2 ZNF516 CDON

1.09e-0419512676522_DN
DrugBromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A

TBC1D2B DICER1 ITGB8 CSPG4 DNM3 ZNF76 HCFC1

1.09e-0419512675665_UP
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A

RYR2 ZFYVE9 TENM3 MED25 ZNF76 RERE ELL

1.12e-0419612673742_DN
DrugPridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A

USP34 FXR2 GART IRF9 DCAF17 BICRAL MAP2K5

1.12e-0419612675860_DN
DrugBrinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

MINK1 RYR2 ZFYVE9 FAM120C SLC47A1 MAP2K5 HCFC1

1.12e-0419612675016_DN
DrugPhenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A

POLH RYR2 ZFYVE9 MED25 RAB2A MAP2K5 HCFC1

1.12e-0419612674538_DN
DrugThioperamide maleate [106243-16-7]; Up 200; 9.8uM; HL60; HT_HG-U133A

RPL10L POLH SPTBN2 NFASC ITGB8 RERE HCFC1

1.12e-0419612673055_UP
DrugDemecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A

FXR2 MINK1 ZNF516 DCAF17 SLC47A1 ZNF76 RERE

1.12e-0419612676269_UP
DrugAcetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A

INHBA MINK1 HAPLN1 MED25 ZNF76 RERE RAB2A

1.12e-0419612674494_DN
DrugNorethindrone [68-22-4]; Down 200; 13.4uM; PC3; HT_HG-U133A

FXR2 POLH HAPLN1 TBC1D4 MED25 ZNF76 RAB2A

1.16e-0419712675055_DN
DrugMethantheline bromide [53-46-3]; Down 200; 9.6uM; PC3; HT_HG-U133A

POLH RYR2 ZFYVE9 KIAA1549L ZNF592 ZNF76 MAP2K5

1.16e-0419712675780_DN
DrugBicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A

RPL10L FXR2 IRF9 ZFYVE9 TRIM62 RERE ELL

1.16e-0419712672796_DN
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A

MINK1 MPDZ ZFYVE9 ADGRG2 ZNF76 RAB2A HCFC1

1.16e-0419712672169_DN
DrugGemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A

FXR2 POLH MINK1 SPTBN2 POLR1G ZNF76 ELL

1.16e-0419712672277_DN
DrugNefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; PC3; HT_HG-U133A

HAPLN1 ZFYVE9 FAM120C MED25 DNM3 MAP2K5 HCFC1

1.19e-0419812673730_DN
DrugBenzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; HL60; HT_HG-U133A

NRBP1 ANK2 CENPB MINK1 DNM3 ZNF76 ULK2

1.19e-0419812672200_DN
DrugMianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

GNPTAB MINK1 RYR2 NUDT6 MAP2K5 PCDH1 ULK2

1.19e-0419812675786_DN
DrugQuinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A

MINK1 IRF9 FAM120C BICRAL LTBP1 MAP2K5 CDON

1.19e-0419812676019_DN
DrugAdrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

RPL10L MINK1 RYR2 LUZP1 IRF9 FAM120C ZNF76

1.19e-0419812675464_UP
DrugPinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A

SPTBN2 RYR2 MED25 MAP2K5 PCDH1 PLXNA1 ELL

1.19e-0419812676356_UP
DrugLoracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A

INHBA GART ZFYVE9 ADGRG2 MED25 ULK2 ELL

1.19e-0419812675492_DN
DrugFamotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A

FXR2 HAPLN1 NUDT6 ZFYVE9 ADGRG2 ZNF76 MAP2K5

1.23e-0419912676665_DN
DrugBemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A

POLH MINK1 TENM3 ADGRG2 FAM120C ELL RPL10

1.23e-0419912675014_DN
DrugNisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A

RPL10L INHBA TBC1D4 FAM120C TRIM62 PLXNA1 CDON

1.23e-0419912676496_DN
DrugMethotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A

SPTBN2 NUDT6 NFATC4 FAM120C MED25 ZNF76 CDON

1.23e-0419912673701_DN
DrugEtanidazole [22668-01-5]; Down 200; 18.6uM; PC3; HT_HG-U133A

TBC1D2B TBC1D4 NUDT6 TRIM62 MAP2K5 HCFC1 CDON

1.23e-0419912675730_DN
DrugProtoveratrine A [143-57-7]; Up 200; 5uM; PC3; HT_HG-U133A

KIF21B VPS13C ITGB8 ZNF516 MED25 ZNF76 RERE

1.23e-0419912676618_UP
DrugMefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; HL60; HG-U133A

FLII MINK1 OCRL GDF9 ZFYVE9 RERE HCFC1

1.23e-0419912671364_DN
DrugCotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A

USP34 DICER1 RYR2 FAM120C LTBP1 RERE MAP2K5

1.23e-0419912671511_UP
DrugTolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A

INHBA TBC1D2B MPDZ MED25 ZNF76 MAP2K5 RPL10

1.23e-0419912671500_UP
DrugPiroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A

RPL10L USP34 SPTBN2 FAM120C ZNF76 HCFC1 RPL10

1.23e-0419912672252_DN
DrugBromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A

RPL10L MINK1 HAPLN1 TENM3 ZNF76 RERE MAP2K5

1.23e-0419912674278_DN
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A

MPDZ KIAA1549L FAM120C TRIM62 MAP2K5 AGTPBP1 CDON

1.27e-0420012677308_DN
DrugLoperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HT_HG-U133A

POLH MINK1 SPTBN2 POLR1G TENM3 HCFC1 ELL

1.27e-0420012674672_DN
Drug(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A

SPTBN2 DICER1 DNM3 SLC47A1 RERE MAP2K5 RPL10

1.27e-0420012676049_DN
Drug4-aminohexanoic Acid

FMR1 FXR2 FXR1

1.27e-04181263CID000138490
DrugNSC46713

FMR1 FXR2 GART DICER1 FXR1 MTHFD1 POLN

1.62e-042081267CID000001139
Diseasefragile X syndrome (implicated_via_orthology)

FMR1 FXR2 FXR1

6.73e-0831213DOID:14261 (implicated_via_orthology)
Diseasemalignant pleural mesothelioma (implicated_via_orthology)

FMR1 FXR2 FXR1

6.73e-0831213DOID:7474 (implicated_via_orthology)
Diseaseautistic disorder (implicated_via_orthology)

RPL10L ANK2 RPL10

2.68e-0741213DOID:12849 (implicated_via_orthology)
Diseasespondyloepiphyseal dysplasia congenita (implicated_via_orthology)

RPL10L HAPLN1 RPL10

1.33e-0661213DOID:14789 (implicated_via_orthology)
Diseasevital capacity

SOX6 USP34 INHBA SPTBN2 IGSF11 ADAMTS8 ZHX2 ITGB8 RYR2 NUDT6 NFATC4 DNM3 LTBP1 KIAA2012 METAP2 PLXNA1

4.66e-05123612116EFO_0004312
DiseaseT-cell acute lymphoblastic leukemia (implicated_via_orthology)

RPL10L RPL10

4.99e-0531212DOID:5603 (implicated_via_orthology)
Diseaseneurotic disorder

SOX6 CTTNBP2 TENM3 DNM3 RERE

6.17e-051011215EFO_0004257
Diseasecomplex trait

ANKRD31 NRBP1 SP3 VIT NBAS LTBP1 TOMM40

1.32e-042711217EFO_0010578
Diseasethyroid peroxidase antibody measurement

TRPM6 CTTNBP2 DICER1 RERE

2.23e-04721214EFO_0005666
Diseasesyndromic X-linked intellectual disability Najm type (implicated_via_orthology)

RPL10L RPL10

3.46e-0471212DOID:0060807 (implicated_via_orthology)
Diseaselysosomal Pro-X carboxypeptidase measurement

GNPTAB RP1

4.59e-0481212EFO_0801777
Diseasepulse pressure measurement

SOX6 USP34 ANK2 INHBA TTC16 ADAMTS8 LUZP1 KIAA1549L KIF15 CSNK1G3 ZNF516 LTBP1 FER1L5 HCFC1 ELL

5.84e-04139212115EFO_0005763
DiseaseAsthma, Occupational

TENM3 HERC2

7.35e-04101212C0264423
DiseaseVENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)

ANK2 RYR2

7.35e-04101212C1631597
Diseasehair colour measurement

SOX6 NRBP1 FLII INHBA MED12L ZNF76 HERC2 PLXNA1 ELL

1.00e-036151219EFO_0007822
Diseaseschizophrenia, anorexia nervosa

FXR1 ZNF592 RERE

1.02e-03481213MONDO_0005090, MONDO_0005351
Diseaseremnant cholesterol measurement

ANKRD31 CSNK1G3 TOMM40 KPNB1

1.04e-031081214EFO_0010815
Diseaselongevity

SOX6 KIF21B MTHFD1 ZNF516 TOMM40 RP1

1.15e-032841216EFO_0004300
Diseasefree cholesterol measurement

ANKRD31 CSNK1G3 TOMM40 KPNB1

1.23e-031131214EFO_0008591
Diseaseaspartate aminotransferase measurement

SOX6 ANKRD31 KIF21B CEBPG OBSCN OCRL POLR1G PTPN11 RAB2A KIAA2012 ELL

1.26e-0390412111EFO_0004736
DiseaseIGFBP-1 measurement

ZNF217 IGSF11

1.26e-03131212EFO_0005118
Diseasetetralogy of Fallot (is_implicated_in)

PTPN11 MTHFD1

1.26e-03131212DOID:6419 (is_implicated_in)
Diseasetotal cholesterol measurement, low density lipoprotein cholesterol measurement

ANKRD31 PTPN11 CSNK1G3 KPNB1

1.27e-031141214EFO_0004574, EFO_0004611
Diseasephospholipids in IDL measurement

ANKRD31 TOMM40 KPNB1

1.28e-03521213EFO_0022164
Diseaseasthma, body mass index

ITGB8 RERE

1.47e-03141212EFO_0004340, MONDO_0004979
Diseaseeating disorder, bipolar disorder

RYR2 FXR1

1.47e-03141212EFO_0005203, MONDO_0004985
Diseaseclonal hematopoiesis mutation measurement

TBC1D4 HERC2 ELL

1.51e-03551213EFO_0020949
Diseaseoptic cup area measurement

ADAMTS8 RERE KPNB1

1.59e-03561213EFO_0006940
DiseaseFEV/FEC ratio

RPL10L USP34 CTTNBP2 VPS13C ITGB8 HAPLN1 KIF15 CSPG4 ZNF516 DCAF17 LTBP1 METAP2 CDON

1.61e-03122812113EFO_0004713
Diseasetotal lipids in large LDL

ANKRD31 TOMM40 KPNB1

1.67e-03571213EFO_0022163
Diseasecholesterol in large LDL measurement

ANKRD31 TOMM40 KPNB1

1.67e-03571213EFO_0021901
DiseaseAlzheimer's disease (implicated_via_orthology)

SOX6 ANK2 TOMM40

1.67e-03571213DOID:10652 (implicated_via_orthology)
Diseaseattention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement

FLII CTTNBP2 MINK1 NFASC IGSF11 RYR2 FXR1 BICRAL MAP2K5 ELL

1.74e-0380112110EFO_0003888, EFO_0007052, MONDO_0002491
Diseasecholesteryl ester measurement, low density lipoprotein cholesterol measurement

PTPN11 CSNK1G3 TOMM40 KPNB1

1.83e-031261214EFO_0004611, EFO_0010351
Diseaseesterified cholesterol measurement

ANKRD31 CSNK1G3 TOMM40 KPNB1

1.94e-031281214EFO_0008589
Diseasetotal lipids in IDL

ANKRD31 TOMM40 KPNB1

1.94e-03601213EFO_0022161
Diseasebiological sex

SOX6 NFASC FXR1 LRRC7 AGTPBP1

2.63e-032301215PATO_0000047
DiseaseCannabis use, age at onset

RYR2 LRRC7

2.72e-03191212EFO_0004847, EFO_0007585
Diseasemaximal midexpiratory flow rate

IGSF11 MED12L

3.02e-03201212EFO_0004313
DiseaseOvarian Failure, Premature

FMR1 GDF9

3.33e-03211212C0085215
Diseaseprogression free survival, ovarian serous carcinoma

VIT PTCHD4

3.65e-03221212EFO_0004920, EFO_1001516
DiseaseDown syndrome (is_marker_for)

GART MTHFD1

3.65e-03221212DOID:14250 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
GRQHGPNVCAVQKVI

TGFBI

41

Q15582
ASGRIIHVGPNQVKV

DCAF17

351

Q5H9S7
GAEQTGIQNKTQIHP

CDY1

191

Q9Y6F8
ISHFTQRAQPAVNGK

ELL

341

P55199
KGQGTVLLHNSVPVA

CSPG4

266

Q6UVK1
IDVKQRSHPGVQNDG

ADAMTS8

716

Q9UP79
VPQNQHITNGTLTGV

ADGRG2

136

Q8IZP9
SNFITGHGIGKNQPR

DICER1

476

Q9UPY3
QGKAQVHPSSVNRDL

DHX29

1251

Q7Z478
QQPGDQNRTISSVHG

AGTPBP1

511

Q9UPW5
RHGQGFTSTPIKLQV

CC2D2B

401

Q6DHV5
GTVTGRLSAKHPNIQ

POLN

566

Q7Z5Q5
VTIRLFQQQKHPQGS

INHBA

171

P08476
EANGIKIGPQHAATN

RAB2A

181

P61019
GITPLHVASKRGNTN

ANK2

266

Q01484
NTNVPKGIGRRKTQH

ANKRD31

721

Q8N7Z5
TAVPKIATGHGQQGV

HCFC1

816

P51610
HRGKRKAVQGAQQPS

FLII

1041

Q13045
VQLVQSGHEVKQPGA

IGHV7-81

21

A0A0B4J1V7
HGSARNIVINPSKIG

MED12L

56

Q86YW9
QVKPIRNLNGHSIGQ

METAP2

321

P50579
NAKTAIIANVHPGSR

KIF15

331

Q9NS87
THGANIQQARKVPGV

FXR2

246

P51116
PAVSVKVNGHDQGQN

GNPTAB

791

Q3T906
LVGKPSHGVRVENSN

LRRC7

586

Q96NW7
GQHQLPIKTVTQNGT

FOXK2

566

Q01167
HGQQGNGTTTVNRKP

HERC2

3286

O95714
THGSNIQQARKVPGV

FXR1

236

P51114
RHSKAQKTGPGILQQ

FOXL2NB

66

Q6ZUU3
FPVRHKIASGNRQQQ

C9orf131

176

Q5VYM1
VHKKTTVGNQGTNLP

DNM3

506

Q9UQ16
PNLTGQHKVTVRAGG

PLXNA1

1211

Q9UIW2
QIHQVSRIDGPTGQK

LTBP1

496

Q14766
NIHGLKVNTRAGPSQ

MAP2K5

116

Q13163
LSIRQQHTNPGAFGK

NUDT6

206

P53370
ENSPIGHSVIQVKAN

PCDH1

291

Q08174
VTGQEIAALKGHPNN

KIF21B

1336

O75037
ESQAQRQIQPGHSAK

KIAA2012

141

Q0VF49
SGFVNGIRQVITNHK

MED25

531

Q71SY5
QIKAGVPGRVHNGVS

KIAA1549L

91

Q6ZVL6
RRNGAVTHIKIQNTG

PTPN11

46

Q06124
GRPGNKTQQVIHIID

CSNK1G3

171

Q9Y6M4
TEVQPRGNQKHGASF

NBAS

36

A2RRP1
QHNGLIKIGSVAPDT

NRBP1

211

Q9UHY1
NQGGLVHPKTSIEDQ

EIF6

156

P56537
GGQRVSFQLHITEPK

OBSCN

1241

Q5VST9
VHRQKISGNIDTPEG

ITGB8

241

P26012
EPITQDKRVSQGHNG

NFASC

181

O94856
TVHPLERGVVQQVKG

CENPB

321

P07199
THGANIQQARKVPGV

FMR1

236

Q06787
PGQHKTLVVTANRGS

IGSF11

366

Q5DX21
VQVESHSGGQKRPAA

BICRAL

681

Q6AI39
TAKRHPSQGQQAVVK

CTTNBP2

1386

Q8WZ74
RQGAQGHRAQVTQPS

DCDC2B

236

A2VCK2
RGPNVLHQNKRATGS

CEP126

936

Q9P2H0
FRQQHGKTVVGQITV

CS

51

O75390
HKVPNAVNGIVNGSL

CDON

1051

Q4KMG0
RQTAQLIVGHVGNKG

FAM120C

191

Q9NX05
KRGHVLGNGSQVTQA

LUZP1

541

Q86V48
FHKGNLQAGQPRTVN

MS4A14

656

Q96JA4
GNENVHRSVKPQILS

KPNB1

701

Q14974
SGQPGTQKVPSKRQH

IRF9

121

Q00978
TRHKQAPGDQVTGIL

GDF9

121

O60383
RADNGHVPIQSKVVN

FCRL2

276

Q96LA5
KGNRTVGSRHVQNGL

WTAP

371

Q15007
KQGQFTHTRNQPKGV

RYR2

3076

Q92736
THTRNQPKGVTQIIN

RYR2

3081

Q92736
RVIPGSHSGINNKLT

CFAP47

1366

Q6ZTR5
IGQAPTEKGHTRTAQ

MTHFD1

546

P11586
VDSQKQRHPSGGVSV

CABLES2

206

Q9BTV7
QQNSTPGVNGISVIH

CEBPG

6

P53567
QSRQGGVQGVLHIPK

LARP1B

546

Q659C4
QAKVFSHRGGNVTLP

HAPLN1

46

P10915
LQASVPGIHKTQNGV

RP1

1091

P56715
KGSVVNVNPTNTRAH

MINK1

991

Q8N4C8
KPQGTVARVHIGQVI

RPL10L

121

Q96L21
GTIKPQLAIHNINGN

GFM2

391

Q969S9
GPALKIQSQVSQHVG

SAMD7

376

Q7Z3H4
PVVKVSIAGQQHQTR

FER1L5

186

A0AVI2
VHVPQGGGKVVSVQA

NFATC4

556

Q14934
KPQGTVARVHIGQVI

RPL10

121

P27635
DVEQRPVVGHSGAQK

PLEKHA4

631

Q9H4M7
QRQKHICGGSIVSPQ

OVCH2

71

Q7RTZ1
GQKLFIPQITRNHSG

PSG9

376

Q00887
HQLGGVVEVPNSKDQ

PTCHD4

151

Q6ZW05
FNGRHVPLSGSQIVK

POLR1G

56

O15446
PVNSVNILKAHGRSQ

TCP1

191

P17987
PQVVSAVSHQGKRNP

POLH

671

Q9Y253
STQGEIRVGPSHQAK

RERE

281

Q9P2R6
RGQITGKITTSRQPH

SPDYE2B

11

A6NHP3
VPNTQSGQREGLIKH

OCRL

211

Q01968
VHANLKVNNVPRSGN

SLC47A1

471

Q96FL8
LVNRKITVPGNFQGH

SSRP1

321

Q08945
QQQPHGVDGKLSSIN

SOX6

516

P35712
NQKQQTPLHVAADRG

ANKDD1B

331

A6NHY2
SATLKRVPQAGGQHA

ADGRG5

91

Q8IZF4
QQLQQNLPKGHETTG

C11orf52

36

Q96A22
APKQGRDHSNTGTVQ

ZNF516

1141

Q92618
GQPGKVQQLHSLRNS

PLEK2

106

Q9NYT0
IVVSGVSPNRQAHSK

TRPM6

1326

Q9BX84
HPTGVAAQTQKLRVG

MPDZ

1896

O75970
RVQHKQQQLPDGTGR

SPTBN2

1816

O15020
QEPSQHRTGAAVQRK

PAPLN

836

O95428
RGQITGKITTSRQPH

SPDYE18

11

P0DV79
GKITTSRQLHPQNEQ

SPDYE21

16

A0A494C086
RGQITGKITTSRQPH

SPDYE2

11

Q495Y8
RGQITGKITTSRQPH

SPDYE6

11

P0CI01
ITPQTIHGVQASGQN

SP3

416

Q02447
QVNHLKRPVSGVGDA

ZNF592

1091

Q92610
ARRKQFNGTVHTVPQ

ZHX1

351

Q9UKY1
KANGNRSGAPNVVVV

VIT

386

Q6UXI7
HVLAGTANPTVAKRN

TENM3

1721

Q9P273
GTQVSQRPGAQALKV

VPS13C

561

Q709C8
RNTKGNSSRVHQPTG

UBQLNL

126

Q8IYU4
HVKQVLVAPGNAGTA

GART

26

P22102
GVQRRVHEGSQKSQP

TBC1D4

321

O60343
GINPAQTAGNVFLKH

UFM1

56

P61960
NAQVIHQLGPGLRSK

TOMM40

161

O96008
HRSQRGGTAVPTSQK

TIMM21

86

Q9BVV7
QQGKTPICRHQGSTD

ULK2

676

Q8IYT8
AVAGVTNHGQKRPLV

ZHX2

396

Q9Y6X8
TNHGQKRPLVTPQAA

ZHX2

401

Q9Y6X8
VSKASPRAQPQQGIH

TMEM221

201

A6NGB7
SNLKSHRPQQNVGVQ

ZNF217

816

O75362
SHGPRKIKATQGQRQ

TTC16

666

Q8NEE8
IHVVTRISGKGNQAA

USP34

3531

Q70CQ2
VQLVQGSSNEHGPVK

VEGFD

16

O43915
GQSHANGKNVQPLRI

TRIM62

456

Q9BVG3
HSAGAVTVLKAPNRQ

TBC1D2B

111

Q9UPU7
QSAGITGVNHRAQPG

ZNF195

101

O14628
LHDSQIPRNGKGQQV

ZNF76

146

P36508
QAISIHNQPRKVTGA

ZFYVE9

1186

O95405
QRVHNGEKPNSVVSV

ZNF181

536

Q2M3W8